Mackenzie Financial Corp Buys 99,599 Shares of Doximity, Inc. (NASDAQ:DOCS)

Mackenzie Financial Corp grew its stake in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) by 87.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 213,195 shares of the company's stock after purchasing an additional 99,599 shares during the quarter. Mackenzie Financial Corp owned approximately 0.11% of Doximity worth $5,978,000 as of its most recent SEC filing.

Other institutional investors also recently made changes to their positions in the company. Bank of New York Mellon Corp grew its holdings in Doximity by 60.6% in the 1st quarter. Bank of New York Mellon Corp now owns 172,855 shares of the company's stock worth $9,004,000 after buying an additional 65,196 shares in the last quarter. US Bancorp DE grew its holdings in Doximity by 325.4% in the 1st quarter. US Bancorp DE now owns 2,646 shares of the company's stock worth $138,000 after buying an additional 2,024 shares in the last quarter. Cambridge Investment Research Advisors Inc. boosted its stake in Doximity by 417.4% during the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 21,099 shares of the company's stock valued at $1,099,000 after purchasing an additional 17,021 shares in the last quarter. Natixis Advisors L.P. bought a new position in Doximity during the 1st quarter valued at $983,000. Finally, BlackRock Inc. boosted its stake in Doximity by 53.6% during the 1st quarter. BlackRock Inc. now owns 2,052,183 shares of the company's stock valued at $106,898,000 after purchasing an additional 716,547 shares in the last quarter. 87.19% of the stock is owned by institutional investors.

Doximity Stock Down 0.8 %

Shares of DOCS traded down $0.19 during mid-day trading on Friday, reaching $24.63. The company's stock had a trading volume of 1,679,206 shares, compared to its average volume of 1,637,008. The business has a fifty day moving average of $27.53 and a 200 day moving average of $26.16. The company has a market cap of $4.59 billion, a price-to-earnings ratio of 37.32, a price-to-earnings-growth ratio of 3.10 and a beta of 1.17. Doximity, Inc. has a 1 year low of $19.71 and a 1 year high of $37.06.

Doximity (NASDAQ:DOCS - Get Free Report) last announced its quarterly earnings data on Thursday, February 8th. The company reported $0.25 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.19 by $0.06. Doximity had a return on equity of 16.08% and a net margin of 29.39%. The business had revenue of $135.28 million during the quarter, compared to analyst estimates of $127.46 million. On average, analysts predict that Doximity, Inc. will post 0.72 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on the company. SVB Leerink assumed coverage on Doximity in a research note on Monday, February 26th. They set a "market perform" rating and a $32.00 price target for the company. Bank of America increased their price objective on Doximity from $29.00 to $32.00 and gave the company a "neutral" rating in a research report on Tuesday, January 23rd. JPMorgan Chase & Co. increased their price objective on Doximity from $22.00 to $25.00 and gave the company an "underweight" rating in a research report on Friday, March 15th. Evercore ISI reiterated an "in-line" rating and set a $30.00 price objective on shares of Doximity in a research report on Tuesday, April 2nd. Finally, Leerink Partnrs reiterated a "market perform" rating on shares of Doximity in a research report on Monday, February 26th. Two analysts have rated the stock with a sell rating, ten have issued a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus price target of $28.82.

Insider Buying and Selling

In related news, Director Kira Scherer Wampler sold 2,500 shares of the stock in a transaction on Monday, April 1st. The stock was sold at an average price of $26.97, for a total transaction of $67,425.00. Following the completion of the sale, the director now directly owns 10,258 shares in the company, valued at $276,658.26. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. 39.40% of the stock is owned by corporate insiders.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.